Cresset Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.44M | Buy |
77,233
+8,272
| +12% | +$261K | 0.01% | 492 |
|
|
2025
Q1 | $2.29M | Sell |
68,961
-2,804
| -4% | -$93.1K | 0.01% | 496 |
|
|
2024
Q4 | $2.47M | Buy |
71,765
+7,557
| +12% | +$260K | 0.01% | 480 |
|
|
2024
Q3 | $2.57M | Buy |
64,208
+3,830
| +6% | +$153K | 0.01% | 666 |
|
|
2024
Q2 | $1.82M | Buy |
60,378
+9,516
| +19% | +$287K | 0.01% | 739 |
|
|
2024
Q1 | $1.71M | Buy |
+50,862
| New | +$1.71M | 0.01% | 710 |
|